We last talked about IDXG on the 16th of last month. (Please excuse us for being currently unable to provide the link to that report like we normally would, as our primary servers are located in Houston, and our service provider is still recovering in the wake of Hurricane Harvey.) Subsequent to that mention, we observed a low of .72 in IDXG, and the run we’ve seen has been pretty impressive.
Yesterday the stock hit 1.73, which represents a 140% increase, and the stock closed with strength just below its high of day, so we’ll be interested to see if there will be further gains in store. The key for IDXG will be to maintain above the NASDAQ minimum bid requirement of a dollar per share on any pullbacks.
Insmed, Inc. INSM – Options Update
We highlighted our interest in a set of options for INSM in yesterday’s report to try to take advantage of the flux in activity caused by the company’s positive Phase III results on its rare lung disease treatment study.
We saw the beginnings of what could be a good idea that we’ll want to continue tracking in the INSM 09/15 $27-30 Calls. The $27’s we’re the only ones that were pushed into the money, and they did manage an intraday run from a low of .95 to 1.60 for a 68% swing on the day. We’ll continue to keep an eye on these contracts if INSM can manage to record higher lows over the next few sessions.
Extended Watchlist:
VSTM, VYGR, BCRX, PTN, CBIO, IMUN, PLX